SCHEMBL30225525

SCHEMBL30225525

CC1CCC(=O)N(n2c(=O)[nH]c3ccccc32)C1=O

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ DAO P14920 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ CHRM2 P08172 2/20 0.38
▸ CHRM4 P08173 2/20 0.38
▸ CHRM1 P11229 2/20 0.38
▸ CHRM3 P20309 1/20 0.38
▸ OPRM1 P35372 3/20 0.38
▸ OPRK1 P41145 2/20 0.38
▸ OPRL1 P41146 2/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23832547 0.78 LMNA (0.48) LMNAMAPTPOLBMEN1CYP1A2
SCHEMBL25433262 0.68 SRD5A1 (0.40) —
SCHEMBL5657114 0.66 OPRM1 (0.45) DAOHPGDCHRM2CHRM4CHRM1
SCHEMBL104742 0.65 LMNA (0.63) LMNAMAPTPOLBMEN1CYP1A2
SCHEMBL8556280 0.65 PIK3CD (0.35) MAPTKMT2AHPGDCHRM2CHRM4
SCHEMBL2718551 0.64 LMNA (0.51) LMNAMAPTPOLBMEN1CYP1A2
SCHEMBL16455979 0.64 CHRM1 (0.62) MAPTMEN1KMT2ACHRM2CHRM4
SCHEMBL319049 0.63 CHRM1 (0.70) CHRM2CHRM4CHRM1CHRM3OPRM1
Water SCHEMBL28348965 0.63 PIK3CD (0.34) MAPTKMT2AHPGDCHRM2CHRM4
Hydrochloric Acid SCHEMBL10768662 0.63 PIK3CD (0.34) MAPTKMT2AHPGDCHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117715904-A CDK2 degrading agents and uses thereof 凯麦拉医疗公司 2024-03-15 — — CN disclosed
CN-116867758-A IRAK degradation agents and uses thereof 凯麦拉医疗公司 2023-10-10 — — CN disclosed
EP-4121043-A1 MDM2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2023-01-25 — — EP disclosed
Send feedback